Tesaro Plans to Raise $81M IPO, After Raising $121M in VC
June 21, 2012- Share:
Tesaro has set the terms for its IPO and plans to list on the NASDAQ under the symbol TSRO. The oncology-focused biotech will offer 6 million shares priced between $12 to $15 apiece—calculated at the midpoint of the range, Tesaro would raise $81 million. New Enterprise Associates holds a 50.3% pre-IPO stake; InterWest Partners holds 12.7%; and Kleiner Perkins Caufield & Byers holds 9.5%. Tesaro secured $101 million in Series B financing in June 2011 and $60 million in Series A financing in May 2010.
- Share:
-
-
-
-